Advancing patient-focused approaches in the future of OSD manufacturing

Oral solid dose (OSD) therapies remain one of the most widely used drug delivery formats worldwide, offering convenience, stability and flexible dosing options for patients. As drug pipelines evolve, manufacturers face increasing pressure to scale production, manage complex APIs and support more patient-centric formulations.

In this eBook, “Helping deliver a smarter, faster and more patient-centric future for OSD manufacturing,” explore the trends shaping the next generation of OSD development and production.

Download the eBook to explore:

  • Four key trends influencing the future of OSD manufacturing
  • How Pharma 5.0 technologies such as AI, automation and digital systems are influencing production processes
  • The growing importance of patient-centric dosage formats and personalized therapies
  • Strategies for addressing manufacturing challenges associated with poorly soluble drugs and highly potent APIs
  • The role of flexible manufacturing and packaging capabilities in supporting evolving OSD programs

Powered by Pfizer expertise, Pfizer CentreOne provides commercial manufacturing capabilities designed to support your tablet, capsule and complex OSD products across a wide range of formulations and delivery technologies.

Download the eBook to explore insights that can help inform your OSD manufacturing strategy.

Pfizer CentreOne

Free Download

Fill out the form